
NGM Biopharmaceuticals, Inc.
USD1.54
-0.02 (-1.28%)
CEO
David J. Woodhouse
IPO Date
2019-04-04
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.56
Prev. Close
$1.56
Day Low
$1.54
Day High
$1.57
52W Low
$0.60
52W High
$4.69
Market Cap
$0.13B
Volume
2.21M
| 7,000 |
| $1.55 |
| 8 Apr 2024 | Hooper Suzanne Sawochka | director | D-Return | Disposed | 24,000 | $13.35 |
| 8 Apr 2024 | Hooper Suzanne Sawochka | director | D-Return | Disposed | 19,619 | $17.24 |
| 8 Apr 2024 | Hooper Suzanne Sawochka | director | D-Return | Disposed | 16,806 | $20.37 |
| 8 Apr 2024 | Hooper Suzanne Sawochka | director | D-Return | Disposed | 25,000 | $12.06 |
| 8 Apr 2024 | Lieu Hsiao D | Chief Medical Officer | D-Return | Disposed | 39,750 | $0.00 |
| 8 Apr 2024 | Lieu Hsiao D | Chief Medical Officer | D-Return | Disposed | 150,000 | $0.84 |
| 8 Apr 2024 | Lieu Hsiao D | Chief Medical Officer | U-Tender | Disposed | 19,349 | $1.55 |
| 8 Apr 2024 | Lieu Hsiao D | Chief Medical Officer | D-Return | Disposed | 159,000 | $4.36 |